5 years ago

Abzena Secures $10 Million in Growth Funding from Biospring Partners

  • Abzena, a Cambridge, UK-based global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), raised $10 million in growth funding from Biospring Partners

  • The company intends to use the new capital to accelerate its growth plans.

      • ProblemTechnology

      "to accelerate its growth plans"

      Solution

      "use the new capital"

      Covered on